Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia
Abstract Background Chemotherapy is still the standard regimen for treating acute myeloid leukemia (AML) and its disappointing efficacy requires the urgent need for new therapeutic targets. It is well known that immune response plays an increasingly significant role in the pathogenesis of AML. Metho...
Shranjeno v:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2023-09-01
|
| Serija: | Cancer Medicine |
| Teme: | |
| Online dostop: | https://doi.org/10.1002/cam4.6468 |
| Oznake: |
Brez oznak, prvi označite!
|